Clinical Value of Metagenomic Next-Generation Sequencing From Blood Samples to Identify Pneumocystis jirovecii Pneumonia in Patients With Human Immunodeficiency Virus
Open Forum Infectious Diseases · 27.03.2025 · 12 (4)
DOI: 10.1093/ofid/ofaf170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 18.03.2025. Verfasst von Hongyu Luo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: the Scientific Research Program of FuRong Laboratory, Clinical Medical Research Center for Viral Hepatitis in Hunan Province, Hunan Provincial Health Commission Research Program.
Abstract (Originalsprache)
Background
The aim of this study was to evaluate the clinical value of metagenomic next-generation sequencing (mNGS) of blood samples for identifying Pneumocystis jirovecii pneumonia (PJP) in patients with human immunodeficiency virus (HIV).
Methods
A total of 76 people with HIV (PWH) with suspected lung infections were enrolled in the study. The patients were divided into two groups: the PJP group and the non-PJP group.All patients underwent pulmonary computed tomography scans, and blood or respiratory tract specimens were subjected to mNGS and conventional microbiological tests. Patient characteristics were collected from their medical records.
Results
Thirty patients were diagnosed with PJP and 46 were confirmed to have non-P jirovecii (Pj) infectious pneumonia. mNGS was conducted on bronchoalveolar lavage fluid samples from 25 patients and on blood samples from 59 patients. Twenty-one of 22 (95.5%) blood samples from the PIP group contained sequences of Pi, with the number of specific reads for circulating Pj sequences ranging from 2 to 2035. In the non-PJP group, 4 blood samples exhibited low Pj sequences, ranging from 1 to 2 reads. The sensitivity and specificity for blood samples were 95.5% (95% confidence interval [CI], 91.2%-98.4%) and 90.0% (95% Cl, 89.5%-100%), respectively.
Conclusions
Our study indicates that mNGS of blood samples exhibits high sensitivity and specificity for diagnosing PJP in PWH. Caution should be exercised when interpreting low Pj mNGS read counts in blood samples; the definitive diagnosis of PJP relies on the synthesis of clinical data with Pj mNGS results. Further studies are necessary to validate this finding.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Infectious Diseases, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
- FuRong Laboratory, Changsha, Hunan, China.
- Clinical Medical Research Center for Viral Hepatitis in Hunan Province, Changsha, Hunan, China.
Förderung
- the Scientific Research Program of FuRong Laboratory
- Clinical Medical Research Center for Viral Hepatitis in Hunan Province
- Hunan Provincial Health Commission Research Program
Zitieren
APA
Luo, H., Jiang, Y., He, Y., & Zhou, H. (2025). Clinical Value of Metagenomic Next-Generation Sequencing From Blood Samples to Identify Pneumocystis jirovecii Pneumonia in Patients With Human Immunodeficiency Virus. Open Forum Infectious Diseases, 12(4). https://doi.org/10.1093/ofid/ofaf170
Vancouver
Luo H, Jiang Y, He Y, Zhou H. Clinical Value of Metagenomic Next-Generation Sequencing From Blood Samples to Identify Pneumocystis jirovecii Pneumonia in Patients With Human Immunodeficiency Virus. Open Forum Infectious Diseases. 2025;12(4). doi:10.1093/ofid/ofaf170
BibTeX
@article{Luo2025,
author = {Luo, Hongyu and Jiang, Yongfang and He, Yan and Zhou, Huaying},
title = {Clinical Value of Metagenomic Next-Generation Sequencing From Blood Samples to Identify Pneumocystis jirovecii Pneumonia in Patients With Human Immunodeficiency Virus},
journal = {Open Forum Infectious Diseases},
year = {2025},
volume = {12},
number = {4},
doi = {10.1093/ofid/ofaf170}
}
EUVIMED